💊 Aurobindo Pharma – Strong Breakout After Long Accumulation Base!

Technical Analysis The stock has broken out from a 6-month accumulation range, indicating strong institutional activity after prolonged consolidation. Price has reclaimed the AVWAP support zone near ₹1,080, which acted as a base for this breakout. Elliott Wave structure suggests that the corrective phase has completed, and the stock is entering an early Wave 3 expansion, typically the most powerful leg. A bullish MACD shift confirms a change in momentum, supported by a wide-bodied breakout candle — a sign of strength. The breakout above ₹1,277 opens up a measured target of ₹1,500–₹1,540, matching the height of the previous congestion zone. Fundamental Strength Aurobindo Pharma continues to maintain leadership in formulations and API exports with a robust global footprint. Healthy ROCE, consistent earnings visibility, and strong US pipeline expansion support long-term stability. Continuous investments in specialty products, injectables, and capacity enhancement strengthen future growth potential. View Bias: Bullish continuation after structural breakout. Immediate Support: ₹1,170–₹1,180 (breakout retest zone). Momentum Target: ₹1,500–₹1,540. Invalidation: Weekly close back below ₹1,120.